(VIANEWS) – Shares of Viking Therapeutics (NASDAQ Composite: VKTX) dropped by a staggering 18.45% in 7 days from $5.15 to $4.20 at 18:10 EST on Sunday, after five successive sessions in a row of losses. NASDAQ Composite is dropping 0.96% to $14,935.90, after four successive sessions in a row of losses.

Viking Therapeutics’s last close was $4.20, 58.37% below its 52-week high of $10.09.


Today’s last reported volume for Viking Therapeutics is 697591 which is 4.19% below its average volume of 728163.

The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.


Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.70%, a negative 0.59%, and a positive 2.65%, respectively.

Viking Therapeutics’s highest amplitude of average volatility was 5.26% (last week), 3.02% (last month), and 2.65% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Viking Therapeutics’s stock is considered to be overbought (>=80).

Viking Therapeutics’s Stock Yearly Top and Bottom Value

Viking Therapeutics’s stock is valued at $4.20 at 18:11 EST, way below its 52-week low of $4.81.

Viking Therapeutics’s Moving Average

Viking Therapeutics’s value is way below its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.

More news about Viking Therapeutics (VKTX).


Please enter your comment!
Please enter your name here